Japan Pharma Wholesaler To Invest In Local Drug Innovations
This article was originally published in PharmAsia News
Executive Summary
Medipal Holdings, a major Japan drug wholesaler, plans to enter the drug-maker side of the market by investing as much as $20.3 million a year in startups with innovative drugs and then buying their exclusive rights.